Header Logo

Connection

Tracy Lieu to Influenza Vaccines

This is a "connection" page, showing publications Tracy Lieu has written about Influenza Vaccines.
Connection Strength

2.457
  1. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. Pharmacoepidemiol Drug Saf. 2013 Apr; 22(4):335-44.
    View in: PubMed
    Score: 0.335
  2. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:291-7.
    View in: PubMed
    Score: 0.316
  3. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Arch Pediatr Adolesc Med. 2011 Feb; 165(2):112-8.
    View in: PubMed
    Score: 0.290
  4. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006 Oct; 12(10):1548-58.
    View in: PubMed
    Score: 0.219
  5. Parental perspectives on influenza vaccination among children with asthma. Public Health Rep. 2006 Mar-Apr; 121(2):181-8.
    View in: PubMed
    Score: 0.211
  6. Influenza vaccination among children with asthma in medicaid managed care. Ambul Pediatr. 2006 Jan-Feb; 6(1):1-7.
    View in: PubMed
    Score: 0.208
  7. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005 Mar 21; 3:18.
    View in: PubMed
    Score: 0.197
  8. Is it time to give influenza vaccine to healthy infants? N Engl J Med. 2000 Jan 27; 342(4):275-6.
    View in: PubMed
    Score: 0.138
  9. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood). 2012 Nov; 31(11):2518-27.
    View in: PubMed
    Score: 0.084
  10. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol. 2012 Jun 01; 175(11):1120-8.
    View in: PubMed
    Score: 0.081
  11. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol. 2012 Jun 01; 175(11):1100-9.
    View in: PubMed
    Score: 0.081
  12. Financing and systems barriers to seasonal influenza vaccine delivery in community settings. Vaccine. 2011 Dec 06; 29(52):9632-9.
    View in: PubMed
    Score: 0.078
  13. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med. 2011 Aug; 41(2):121-8.
    View in: PubMed
    Score: 0.077
  14. Near real-time vaccine safety surveillance with partially accrued data. Pharmacoepidemiol Drug Saf. 2011 Jun; 20(6):583-90.
    View in: PubMed
    Score: 0.076
  15. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010 Jan 15; 171(2):177-88.
    View in: PubMed
    Score: 0.068

© 2024 Kaiser Permanente